Plasma lipid profile associates with the improvement of psychological well-being in individuals with perceived stress symptoms.

Stefania Noerman, Anton Klåvus, Elina Järvelä-Reijonen, Leila Karhunen, Seppo Auriola, Riitta Korpela, Raimo Lappalainen, Urho M Kujala, Sampsa Puttonen, Marjukka Kolehmainen, Kati Hanhineva

Journal: Scientific reports 2020;10(1):2143

PMID: 32034255

Abstract

Psychological stress is a suggested risk factor of metabolic disorders, but molecular mediators are not well understood. We investigated the association between the metabolic profiles of fasting plasma and the improvement of psychological well-being using non-targeted liquid chromatography-mass spectrometry (LC-MS) platform. The metabolic profiles of volunteers participating in the face-to-face intervention group (n = 60) in a randomised lifestyle intervention were compared to ones of controls (n = 64) between baseline and 36-week follow-up. Despite modest differences in metabolic profile between groups, we found associations between phosphatidylcholines (PCs) and several parameters indicating stress, adiposity, relaxation, and recovery. The relief of heart-rate-variability-based stress had positive, while improved indices of recovery and relaxation in the intervention group had an inverse association with the reduction of e.g. lysophosphatidylcholines (LPC). Interleukin-1 receptor antagonist and adiposity correlated positively with the suppressed PCs and negatively with the elevated plasmalogens PC(P-18:0/22:6) and PC(P-18:0/20:4). Also, we found changes in an unknown class of lipids over time regardless of the intervention groups, which also correlated with physiological and psychological markers of stress. The associations between lipid changes with some markers of psychological wellbeing and body composition may suggest the involvement of these lipids in the shared mechanisms between psychological and metabolic health.

Address: Institute of Public Health and Clinical Nutrition, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland.; School of Pharmacy, University of Eastern Finland, Kuopio, Finland.; LC-MS Metabolomics Centre, Biocentre Kuopio, Kuopio, Finland.; Medical Faculty, Pharmacology and Human Microbe Research program, University of Helsinki, P.O. Box 63, FI-00014, Helsinki, Finland.; Department of Psychology, Faculty of Education and Psychology, University of Jyväskylä, PO Box 35, FI-40014, Jyväskylä, Finland.; Faculty of Sport and Health Sciences, University of Jyväskylä, P.O. Box 35, FI-40014, Jyväskylä, Finland.; Finnish Institute of Occupational Health, P.O. Box 40, FI-00251, Helsinki, Finland.; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland. [email protected].; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland.; LC-MS Metabolomics Centre, Biocentre Kuopio, Kuopio, Finland.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.